Chorus Sleep Trial

Sponsor
Chorus Wellness Inc. (Industry)
Overall Status
Recruiting
CT.gov ID
NCT05434143
Collaborator
(none)
60
1
2
4.5
13.3

Study Details

Study Description

Brief Summary

This pilot study will evaluate the feasibility of a 6-week intervention using Chorus Sleep's ios app to improve sleep quality, reduce stress, and reduce depression and anxiety using a randomized controlled design.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Chorus Sleep
N/A

Detailed Description

Chorus Sleep is a successful wellness company with a loyal and growing clientele, and considerable qualitative and anecdotal evidence for its efficacy at reducing stress, and improving sleep quality. It builds upon existing meditation and mindfulness practices with well documented efficacy for reducing pain, improving mental health, and reducing stress. Further its innovative approach - including the use of popular music and breathwork patterns that elicit stimulating and novel sensations and physiological activity - may removes barriers to participation and engagement of many traditional meditation and mindfulness practices. Prior research evaluating the efficacy of audio meditation using the Calm app found use of the app for eight weeks significantly decreased daytime fatigue and sleepiness and pre-sleep arousal compared to a wait-list control group. Further, use of the calm app for 8 weeks was associated with greater improvements in depression and anxiety symptoms, and those effects were mediated by lower pre-sleep arousal. This study will investigate whether Chorus Sleep's innovation in auditory app-based sleep inventions will demonstrate similar efficacy.

This study has the following objectives:
  1. Pilot a randomized controlled trial on Chorus sleep to evaluate feasibility.

  2. Evaluate the effect of Chorus sleep practice at improving sleep quality.

  3. Evaluate the effect of Chorus sleep practice at reducing perceived stress, depression, and anxiety, both directly and indirectly through improved sleep quality.

  4. Characterize habit formation of Chorus sleep practice

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Masking Description:
This is a waitlist controlled design to a behavioral intervention. Assignment will not be masked.
Primary Purpose:
Treatment
Official Title:
Chorus Sleep Randomized Controlled Trial
Actual Study Start Date :
May 16, 2022
Anticipated Primary Completion Date :
Sep 30, 2022
Anticipated Study Completion Date :
Sep 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Chorus Sleep

During the 6-week intervention, participants will receive daily reminders to complete their daily sleep log and a link to a chorus sleep class for them to listen to that night. The daily sleep class involve listening to 15 minute audio sessions, which include guided mediation and breathing exercises. Participants will be encouraged to complete classes every day but will be asked to complete classes at least 3 times per week in order to be considered as adhering to the intervention. Participation will be tracked based on participants self-reports in the daily sleep logs. Participants who did not adhere to the intervention will be excluded from per-protocol analyses. Participants will complete surveys online at baseline, after 3 weeks, and after 6 weeks. The baseline questionnaires will include demographic information.

Behavioral: Chorus Sleep
During the 6-week intervention, participants will receive daily reminders to complete their daily sleep log and a link to a chorus sleep class for them to listen to that night. The daily sleep class involve listening to 15 minute audio sessions, which include guided mediation and breathing exercises.

No Intervention: Waitlist

Participants will be placed on a 6 week waitlist to access the chorus sleep app. There will be no daily activities for them to complete during those 6 weeks. Participants will complete surveys online at baseline, after 3 weeks, and after 6 weeks. The baseline questionnaires will include demographic information.

Outcome Measures

Primary Outcome Measures

  1. Preliminary effects of the Chorus Sleep app on sleep disturbance, as assessed by changes in participants' self-reported sleep quality from pre- to post- 6-week intervention period [Within 24 hours pre-and within 1 week post- 6 week intervention]

    Change in total score on the PROMIS Sleep Disturbance Scale from baseline to 6-week follow-up. Mean scores across the 8 items will be used. Items are a 5-point scale from 1-5. Therefore, the range of possible change scores is from -4 to 4, where a lower negative score corresponds with greater decreases in sleep disturbance, a higher score corresponds with greater increases in sleep disturbance, and 0 indicates no change.

Secondary Outcome Measures

  1. Change in perceived stress [Within 24 hours pre-and within 1 week post- 6 week intervention]

    Change in perceived stress on the Perceived Stress Scale-10 from baseline to 6-week follow-up. Mean scores across the 10 items will be used. Items are on a 5-point scale from 1-5. Therefore, the range of possible change scores is from -4 to 4, where lower negative scores correspond with greater decreases in perceived stress, higher positive scores correspond with greater increases in perceived stress, and 0 indicates no change.

  2. Change in depression symptoms [Within 24 hours pre-and within 1 week post- 6 week intervention]

    Change in depression symptoms on the PROMISĀ® Item Bank v1.0 - Emotional Distress - Depression-Short Form 8a from baseline to 6-week follow-up. Mean scores across the 8 items will be used. Items are on a 5-point scale from 1-5. Therefore, the range of possible change scores is from -4 to 4, where lower negative scores correspond with greater decreases in depression, higher positive scores correspond with greater increases in depression, and 0 indicates no change.

  3. Change in anxiety symptoms from baseline to 6-week follow-up. [Within 24 hours pre-and within 1 week post- 6 week intervention]

    Change in anxiety symptoms on the PROMISĀ® Item Bank v1.0 - Emotional Distress - Anxiety - Short Form 8a from baseline to 6-week follow-up. Mean scores across the 8 items will be used. Items are on a 5-point scale from 1-5. Therefore, the range of possible change scores is from -4 to 4, where lower negative scores correspond with greater decreases in anxiety, higher positive scores correspond with greater increases in anxiety, and 0 indicates no change.

  4. Demand, based on frequency of use of the Chorus Sleep app [Recorded continuously throughout 6-week intervention]

    The percentage of days in which participants use the chorus sleep app over the course of the 6 week study period.

Other Outcome Measures

  1. Daily self-reported sleep disturbance, as measured by time to fall asleep, on the in-app sleep survey. [Recorded daily throughout the 6 week intervention (intervention group only)]

    Daily reports of time to fall asleep reported on the in-app daily sleep survey with options: Fell asleep within 15 minutes, Fell asleep within 16-30 minutes, Fell asleep within 31-60 minutes, Fell asleep after 60 minutes.

  2. Daily self-reported sleep disturbance, as measured by number of awakenings on the in-app sleep survey [Recorded daily throughout the 6 week intervention (intervention group only)]

    Daily reports of number of awakenings on the in-app sleep survey with options from 0-more than 4 times in increments of 1.

  3. Daily self-reported sleep disturbance, as measured by total time awake on the in-app sleep survey. [Recorded daily throughout the 6 week intervention (intervention group only)]

    Daily reports of number of awakenings on the in-app sleep survey with the following options: 0-30 minutes, 31-60 minutes, 1-2 hours, 2 or more hours

  4. Habit formation [within 1 week post- 6 week intervention]

    Habit formation for using the Chorus Sleep App will be measured using an adaptation of the Self-Report Behavioral Automaticity Index. Mean scores will be used across 4 items. Possible scores range from 1-5, where higher scores indicate greater automaticity.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Fluent English speakers

  • Have an Apple Iphone 8 or later

  • Have a bed to sleep in consistently every night

Exclusion Criteria:
  • Narcolepsy

  • night shift or shift work for more than 2 nights per week.

  • Used the Chorus sleep app more than one time prior to the beginning of the trial.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Online San Francisco California United States 94103

Sponsors and Collaborators

  • Chorus Wellness Inc.

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Chorus Wellness Inc.
ClinicalTrials.gov Identifier:
NCT05434143
Other Study ID Numbers:
  • CS-0001
First Posted:
Jun 27, 2022
Last Update Posted:
Jul 28, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Chorus Wellness Inc.
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 28, 2022